Optimizing clinical drug product performance: applying Biopharmaceutics Risk Assessment Roadmap (BioRAM) and the BioRAM Scoring Grid

Paul A. Dickinson, Filippos Kesisoglou, Talia Flanagan, Marilyn N. Martinez, Hitesh B. Mistry, John R. Crison, James E. Polli, Maria T. Cruañes, Abu T. M. Serajuddin, Anette Müllertz, Jack A. Cook, Arzu Selen